RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

Nanobodies—miniature proteins—derived from camel antibodies demonstrated powerful potential to accurately and safely deliver ...

Image of a HER2-positive hybrid cell cluster stained with nanobodies. Credit: Debjani Pal/ORNL, U.S. Dept. of Energy ...

The U.S. government and academic labs are pushing multiple universal vaccine candidates through early clinical trials, targeting influenza strains and coronaviruses that mutate faster than today’s ...

Wyss Institute's DoriVac combined vaccine and adjuvant technology uses nanoscale precision enabled by DNA origami to induce broad immunity against ...

A futuristic “DNA origami” vaccine platform may one day outperform mRNA shots while being easier to produce and distribute. Credit: Shutterstock Scientists have developed a new DNA origami–based ...

Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...

A multi-disciplinary research team at the Wyss Institute at Harvard University, Dana-Farber Cancer Institute, and ...

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

From endometriosis and cervical cancer, to diabetes, vitamin D deficiency and pollution exposure, scientists are finding period blood offers a window into women's wellbeing.

“Imagine getting a nasal spray in the fall months that protects you from all respiratory viruses, including COVID-19, influenza, respiratory syncytial virus, and the common cold, as well as bacterial ...